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NEURAL-IMMUNE-EFFECTOR (NIE) CROSS-TALK SN VASCULAR 
TROPHOBIOLOGY: PROPOSAL FOR NEW AND NOTYET EXPLOITED 
PUR1NERGSC REGULATORY MECHANISMS 
H In a state-of-the-art approach, Dr. Hass6ssian 
(1) presents purinoceptor-mediated vasoconstric- 
tion/vasodilation mechanisms of the pulmonary cir- 
culation. He focuses on P2 purinoceptors of smooth 
muscle cells, endothelial cells, platelets and mast 
cells, without addressing P1 (adenosine) 
purinoceptors. 
Recently, the Burnstock's purinoceptorology (1, his 
Refs 3,4,7,10-12,33,35,45,46,48,51,66,70,71, 
76,78,100, and two personal communications) is 
"arborizing" into a variety of members of P: and P2 
purinoceptor families classified by the International 
Union of Pharmacology (1, his Ref 12). 
Here we would like to add some possible, new and 
not yet exploited, purinergic regulatory mechanisms 
to the Hass6ssian's work (see 1, his Fig. 3). Accord- 
ingly, we shall briefly focus on the involvement of 
connective tissue (adventitial) mast cells (Fig. 1) 
and their interactions with perivascular nerves and 
medial smooth muscle cells. 
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Figure 1. Biological active substances released from the activated connective tissue mast cell. The mast 
cell is a receptor-bearing cell, which releasesplasmalemma-derivedlipid mediators, preformed secretory 
granule-stored mediators, and newly synthesized cytokines, including nerve growth factor (NGF). IL - 
interleukin, LT- leukotriene, PG-prostaglandin, PAF-platelet activating factor, 5-HT- 5-hydroxytriptamine, 
GM-CSF - granulocyte-macrophage colony-stimulating factor, TNF - Tumor necrosis factor, ATP - 
adenosine-S'-triphosphate, NO - nitric oxide. This figure is an enriched version of Fig. 1 of Huang (36). 
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Recent studies show that (i) mast cells and other 
immune cells occur in close proximity to nerves (2-7), 
(ii) neurotransmitters, including ATP (1,8,9) and 
adenosine (10), induce mast cell degranulation, (iii) 
picomolar doses of substance P (SP) result in 
"priming" of mast cells (11), (iv) activated macroph- 
ages induce NGF synthesis in Schwann cells (12), 







Figure 2. A schematic representation of the hypothetical involvement of neural-immune-effector (NIE) 
components in vascular trophobiological cross-talk, with special reference to some purinoceptor- 
mediated processes. Stimuli acting on perivascular sympathetic, purinergic, parasympathetic and/or 
sensory nerves produce the corresponding release of noradrenaline (NA), neuropeptide Y(NPY), ATP, 
adenosine (A), 5-HT, SP, vasoactive intestinalpolypeptide (VIP),calcitoningene-relatedpeptide (CGRP) 
and/or other neurotransmitters andneurornodulators(l). They act on two types of target cells: adventitial 
mast cells and medial smooth muscle cells, resulting in mast cell activation (2) and regulation of vascu- 
lar tone, respectively. According, a dual neurotrophic effect of NGF released from these target cells is 
depicted (thick arrows). Also shown are the effector cell-derived NGF acting on the mast cell as a 
degranulator (3) and TNFcc (Ref29) acting as a possible inducer of mast cell NO production (Ref30). 
Noteparacrinefeedback loops created at the vascular adventitia. Other immune cells, such as macrophages 
and lymphocytes, and fibroblasts, are not placed in the adventitia. Their possible involvement in NIE 
trophobiological cross-talk should also be kept in mind (Refs 5,6,12,23,31-34, and note Ref 35, where 
Burnstock wrote " that a recent observation in our laboratory that may open new areas of research con- 
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Figure 3. A brie/chronology of the ideogenesis 
oftrophobiological concepts; neural-effector 
(NE), neural-immune (NI), and neural-immune- 
effector (NIE). Also shown are the names of the 
pioneering authors in trophobiology. From 
(23); see also 7,12-14,20,21,24,31-35, 37and 
Refs therein. 
(13) and possess NGF receptors (14) and opiate/ 
opioid receptors (15 and Refs therein), (vi) NGF 
stimulates histamine release from mast cells (14), 
(vii) NGF affects non-neuronal cells thus being 
involved in inflammatory and immune responses, 
and growth/differentiation of mast cells and other 
immune cells (14, their Table 1), i.e. acts both as 
neurotrophin and immunotrophin, (viii) mast cell 
tryptase is involved in the processing of atrial 
natriuretic peptide (16), and, last not least, (ix) mast 
cells synthesize a NO-like substance (17-19); see 
also 1, his Refs. 5,6,17,109-114 for ATP effects on 
mast cells and other immune cells. 
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Inserting such immune logic (say "I") data to the 
classical vascular neurotrophic concept (nerve-ef- 
fector, say "NE", bidirectional interactions; 20-22), 
we (6) have recently proposed a NIE cross-talk 
hypothesis in vascular trophobiology ( Fig. 2).It also 
appears to be a new and not yet exploited area in 
general trophobiology (Fig. 3). Note that NIE may 
also mean neural-immune-endocrine in a sense of 
neuroendocrine-immune interactions that are more 
studied (13,14,24, and Refs therein) than the NIE 
cross-talk herein discussed. 
We hope that further studies on NIE trophobiological 
hypothesis may have some potential implications in 
the pathogenesis of human diseases (10,12-15,23- 
28, and 1, his Refs 5,6,115-118) and in the develop- 
ment of, for example, new selective Pt (10) and P2 
(1) purinoceptor and histamine H3 receptor (7) ago- 
nists or antagonists for their therapies. 
In direct reference to the pulmonary circulation 
purinergic regulation (1), we would like to address 
the following "NIE" questions: (i) may mast cell 
production of NO (17-19,38. see also Fig. 2) induce 
vasodilation as an ATP-induced NO release from 
endothelial cells does it (1), and (ii) how the purinergic 
vasomechanisms of the pulmonary circulation oper- 
ate in mast cell-deficient W/W
V
 mice (25)? 
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